Table 2.
Viral vectors for CRISPR/Cas9 delivery system.
| Delivery | Packaging capacity | Advantages | Disadvantages |
|---|---|---|---|
| Lentivirus | Approximately 10 kb | High transduction efficiency; large cargo size; low immunogenicity; ability to transduce dividing and non-dividing cells in different tissues | Non-specific DNA integration causes cancer risk; complex packaging structure |
| Adenovirus | Approximately 8–10 kb | Efficient delivery; large cargo size | Inflammatory response |
| Adeno-associated virus | Approximately 4.7 kb | Multiple serotypes; low immunogenicity; ability to transduce dividing and non-dividing cells in different tissues | Pre-existing neutralizing antibodies; long-term expression of Cas9 causes off-target effects |